Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassificationLucy R Webster, Shu-Fen Lee, Clare Ringland, et al.Breast Cancer Research and Treatment|October 15, 2013
Distinct nuclear receptor expression in stroma adjacent to breast tumorsKevin C Knower, Ashwini L Chand, Natalie Eriksson, et al.Oncotarget|September 28, 2014
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic diseaseHeidi N Hilton, Tram B Doan, J Dinny Graham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverCatherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.Breast Cancer Research : BCR|March 2, 2006
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resourceGraham J Mann, Heather Thorne, Rosemary L Balleine, et al.Cancer Research|August 17, 2011
Common breast cancer susceptibility loci are associated with triple-negative breast cancerKristen N Stevens, Celine M Vachon, Adam M Lee, et al.European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.Communications Biology|January 19, 2022
Rare germline copy number variants (CNVs) and breast cancer riskJoe Dennis, Jonathan P Tyrer, Logan C Walker, et al.Nature Communications|August 11, 2018
Identification of nine new susceptibility loci for endometrial cancerTracy A O'Mara, Dylan M Glubb, Frederic Amant, et al.Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.Pageof 9